Qiagen N.V. (QGEN)
USD 44.05
(-2.85%)
USD 44.05
(-2.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 650.58 Million USD | -21.06% |
| 2022 | 779.35 Million USD | -10.71% |
| 2021 | 895.24 Million USD | 20.67% |
| 2020 | 715.8 Million USD | 34.74% |
| 2019 | 227.86 Million USD | 13.66% |
| 2018 | 499.46 Million USD | 31.26% |
| 2017 | 380.5 Million USD | 23.15% |
| 2016 | 308.98 Million USD | -14.5% |
| 2015 | 361.36 Million USD | 85.4% |
| 2014 | 359.5 Million USD | 87.93% |
| 2013 | 267.57 Million USD | -49.34% |
| 2012 | 366.5 Million USD | 54.55% |
| 2011 | 288.94 Million USD | -38.81% |
| 2010 | 343.71 Million USD | -28.82% |
| 2009 | 322.36 Million USD | 8.45% |
| 2008 | 262.51 Million USD | 17.39% |
| 2007 | 169.76 Million USD | 58.95% |
| 2006 | 148.02 Million USD | 14.96% |
| 2005 | 128.15 Million USD | 5.02% |
| 2004 | 100.74 Million USD | 28.07% |
| 2003 | 97.72 Million USD | 0.42% |
| 2002 | 81.51 Million USD | 42.09% |
| 2001 | 68.53 Million USD | 3.64% |
| 2000 | 46.98 Million USD | 72.85% |
| 1999 | 45.57 Million USD | 112.43% |
| 1998 | 17.9 Million USD | 101.12% |
| 1997 | 13.17 Million USD | 41.27% |
| 1996 | 8.5 Million USD | 5.0% |
| 1995 | 6.5 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 152.57 Million USD | -16.57% |
| 2024 Q2 | 176.2 Million USD | -204.3% |
| 2023 Q1 | 181.11 Million USD | 34.42% |
| 2023 Q3 | 173.43 Million USD | -1.2% |
| 2023 Q4 | 186.06 Million USD | 7.28% |
| 2023 FY | - USD | -21.06% |
| 2023 Q2 | 175.55 Million USD | -3.07% |
| 2022 Q1 | 268.04 Million USD | 45.57% |
| 2022 Q4 | 134.73 Million USD | -28.54% |
| 2022 FY | - USD | -10.71% |
| 2022 Q2 | 184.34 Million USD | -31.23% |
| 2022 Q3 | 188.53 Million USD | 2.28% |
| 2021 Q2 | 227.48 Million USD | 0.04% |
| 2021 Q4 | 184.13 Million USD | -6.86% |
| 2021 FY | - USD | 20.67% |
| 2021 Q1 | 227.39 Million USD | -21.99% |
| 2021 Q3 | 197.68 Million USD | -13.1% |
| 2020 Q2 | 195.92 Million USD | 55.38% |
| 2020 FY | - USD | 34.74% |
| 2020 Q1 | 126.09 Million USD | -2.44% |
| 2020 Q3 | 201.58 Million USD | 2.89% |
| 2020 Q4 | 291.49 Million USD | 44.6% |
| 2019 FY | - USD | 13.66% |
| 2019 Q1 | 108.1 Million USD | 10.26% |
| 2019 Q2 | 132.41 Million USD | 22.48% |
| 2019 Q3 | 135.76 Million USD | 2.53% |
| 2019 Q4 | 129.24 Million USD | -4.8% |
| 2018 Q4 | 98.05 Million USD | -28.59% |
| 2018 Q3 | 137.31 Million USD | 17.88% |
| 2018 Q2 | 116.48 Million USD | 8.79% |
| 2018 Q1 | 107.07 Million USD | 76.08% |
| 2018 FY | - USD | 31.26% |
| 2017 Q1 | 81.39 Million USD | 1178.62% |
| 2017 Q4 | 60.81 Million USD | -47.55% |
| 2017 FY | - USD | 23.15% |
| 2017 Q3 | 115.93 Million USD | 45.7% |
| 2017 Q2 | 79.56 Million USD | -2.25% |
| 2016 Q4 | 6.36 Million USD | -93.61% |
| 2016 Q1 | 69.03 Million USD | 4.7% |
| 2016 Q2 | 84.48 Million USD | 22.38% |
| 2016 Q3 | 99.66 Million USD | 17.96% |
| 2016 FY | - USD | -14.5% |
| 2015 Q1 | 74.38 Million USD | 124.92% |
| 2015 FY | - USD | 85.4% |
| 2015 Q3 | 96.24 Million USD | 16.29% |
| 2015 Q2 | 82.76 Million USD | 11.26% |
| 2015 Q4 | 65.93 Million USD | -31.49% |
| 2014 Q1 | 84.96 Million USD | 76.35% |
| 2014 Q4 | 33.07 Million USD | -66.8% |
| 2014 FY | - USD | 87.93% |
| 2014 Q2 | 98.95 Million USD | 16.47% |
| 2014 Q3 | 99.62 Million USD | 0.68% |
| 2013 Q1 | 75.53 Million USD | 35.41% |
| 2013 FY | - USD | -49.34% |
| 2013 Q4 | 48.17 Million USD | -45.41% |
| 2013 Q3 | 88.26 Million USD | 722.32% |
| 2013 Q2 | 10.73 Million USD | -85.79% |
| 2012 FY | - USD | 54.55% |
| 2012 Q3 | 89.7 Million USD | -4.78% |
| 2012 Q2 | 94.21 Million USD | 14.47% |
| 2012 Q1 | 82.3 Million USD | 190.24% |
| 2012 Q4 | 55.77 Million USD | -37.82% |
| 2011 Q4 | 28.35 Million USD | -64.37% |
| 2011 Q1 | 78.4 Million USD | -13.09% |
| 2011 Q2 | 86.73 Million USD | 10.63% |
| 2011 FY | - USD | -38.81% |
| 2011 Q3 | 79.58 Million USD | -8.24% |
| 2010 Q1 | 79.31 Million USD | 2.03% |
| 2010 Q2 | 79.19 Million USD | -0.15% |
| 2010 Q3 | 87.05 Million USD | 9.93% |
| 2010 FY | - USD | -28.82% |
| 2010 Q4 | 90.21 Million USD | 3.63% |
| 2009 Q2 | 51.57 Million USD | -21.36% |
| 2009 Q3 | 84.4 Million USD | 63.67% |
| 2009 FY | - USD | 8.45% |
| 2009 Q4 | 77.73 Million USD | -7.91% |
| 2009 Q1 | 65.58 Million USD | 254.05% |
| 2008 Q4 | 18.52 Million USD | -80.83% |
| 2008 FY | - USD | 17.39% |
| 2008 Q1 | 205.1 Million USD | 192.2% |
| 2008 Q3 | 96.61 Million USD | 24.39% |
| 2008 Q2 | 77.66 Million USD | -62.13% |
| 2007 FY | - USD | 58.95% |
| 2007 Q4 | 70.19 Million USD | -16.22% |
| 2007 Q2 | 42.12 Million USD | 5.35% |
| 2007 Q1 | 39.98 Million USD | -7.82% |
| 2007 Q3 | 83.78 Million USD | 98.91% |
| 2006 Q4 | 43.37 Million USD | 15.66% |
| 2006 Q2 | 30.44 Million USD | -4.59% |
| 2006 Q1 | 31.91 Million USD | -22.76% |
| 2006 Q3 | 37.5 Million USD | 23.18% |
| 2006 FY | - USD | 14.96% |
| 2005 Q4 | 41.31 Million USD | 29.34% |
| 2005 FY | - USD | 5.02% |
| 2005 Q1 | 27.01 Million USD | -7.0% |
| 2005 Q2 | 33.27 Million USD | 23.18% |
| 2005 Q3 | 31.94 Million USD | -4.01% |
| 2004 Q4 | 29.04 Million USD | 6.77% |
| 2004 Q3 | 27.2 Million USD | -36.1% |
| 2004 Q2 | 42.56 Million USD | 65.85% |
| 2004 Q1 | 25.66 Million USD | 2.92% |
| 2004 FY | - USD | 28.07% |
| 2003 FY | - USD | 0.42% |
| 2003 Q2 | 17.31 Million USD | -6.62% |
| 2003 Q1 | 23.52 Million USD | -27.09% |
| 2003 Q4 | 24.49 Million USD | 0.61% |
| 2003 Q3 | 19.31 Million USD | 8.14% |
| 2002 FY | - USD | 42.09% |
| 2002 Q1 | 20.29 Million USD | 10.59% |
| 2002 Q2 | 19.3 Million USD | 14.39% |
| 2002 Q3 | 19.3 Million USD | -15.68% |
| 2002 Q4 | 22.61 Million USD | 71.92% |
| 2001 Q3 | 14.05 Million USD | -14.38% |
| 2001 FY | - USD | 3.64% |
| 2001 Q4 | 20.79 Million USD | 27.75% |
| 2001 Q1 | 15.08 Million USD | -25.53% |
| 2001 Q2 | 18.5 Million USD | -9.26% |
| 2000 Q3 | 12.69 Million USD | -31.69% |
| 2000 FY | - USD | 72.85% |
| 2000 Q4 | 24.86 Million USD | 95.89% |
| 2000 Q2 | 8.24 Million USD | 105.99% |
| 2000 Q1 | 10.95 Million USD | -35.52% |
| 1999 FY | - USD | 112.43% |
| 1999 Q1 | 7.55 Million USD | 148.28% |
| 1999 Q2 | 8.92 Million USD | 12.5% |
| 1999 Q3 | 10.18 Million USD | 9.23% |
| 1999 Q4 | 9.35 Million USD | 57.96% |
| 1998 Q3 | 4 Million USD | 48.15% |
| 1998 Q2 | 2.7 Million USD | -10.0% |
| 1998 Q1 | 3 Million USD | 275.0% |
| 1998 FY | - USD | 101.12% |
| 1998 Q4 | 2.9 Million USD | -27.5% |
| 1997 Q2 | 1 Million USD | 11.11% |
| 1997 Q1 | 900 Thousand USD | 102.71% |
| 1997 Q4 | 800 Thousand USD | -33.33% |
| 1997 Q3 | 1.2 Million USD | 20.0% |
| 1997 FY | - USD | 41.27% |
| 1996 Q4 | -33.2 Million USD | -333.8% |
| 1996 Q1 | 2.5 Million USD | 0.0% |
| 1996 FY | - USD | 5.0% |
| 1996 Q3 | 14.2 Million USD | 12.7% |
| 1996 Q2 | 12.6 Million USD | 447.83% |
| 1995 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Agilent Technologies, Inc. | 1.67 Billion USD | 61.206% |
| Charles River Laboratories International, Inc. | 1.03 Billion USD | 36.966% |
| Quest Diagnostics Incorporated | 1.73 Billion USD | 62.437% |
| Danaher Corporation | 7.54 Billion USD | 91.38% |
| Enzo Biochem, Inc. | -8.34 Million USD | 7893.28% |
| IQVIA Holdings Inc. | 3.25 Billion USD | 80.019% |
| Laboratory Corporation of America Holdings | 1.34 Billion USD | 51.787% |
| Mettler-Toledo International Inc. | 1.18 Billion USD | 45.013% |
| Revvity, Inc. | 813.25 Million USD | 20.002% |
| Thermo Fisher Scientific Inc. | 10.8 Billion USD | 93.976% |
| Waters Corporation | 1.02 Billion USD | 36.358% |